Akebia Therapeutics, Inc. (AKBA) Q2 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Akebia Therapeutics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.000 -- 00:00:05.180 Good day and thank you for stopping by. Welcome to the Akibia second quarter 2025 00:00:05.180 -- 00:00:09.700 financial results. At this time, all participants are in listening only mode. 00:00:09.700 -- 00:00:13.660 After the speakers presentation, we'll open up for questions. 00:00:13.660 -- 00:00:17.860 To ask a question during the session, you will need to press star one one on your telephone. 00:00:17.860 -- 00:00:20.960 You'll then hear an automated message advising your hand is raised. 00:00:20.960 -- 00:00:23.900 To withdraw your question, please press star one one again. 00:00:23.900 -- 00:00:26.660 Please be advised that today's call is being recorded. 00:00:26.660 -- 00:00:30.760 I would now like to hand the conference over to your speaker, Mercedes Carrasco, senior 00:00:30.760 -- 00:00:34.720 director of investor relations. Please go ahead. 00:00:35.320 -- 00:00:40.320 Thank you and welcome to Akibia's second quarter 2025 financial results 00:00:40.320 -- 00:00:45.000 and business updates conference call. Please note that a press release was issued earlier 00:00:45.000 -- 00:00:50.480 today, Thursday, August 7th, detailing our second quarter 2025 financial 00:00:50.480 -- 00:00:55.420 results. And that release is available on the investor sections of our website. 00:00:55.420 -- 00:00:59.880 For your convenience, a replay of today's call will also be available on our website 00:00:59.880 -- 00:01:04.680 after we conclude. Joining me for today's call, we have John Butler, chief executive 00:01:04.680 -- 00:01:10.260 officer, Nick Grunz, chief commercial officer, and Eric Ostrowski, chief financial 00:01:10.260 -- 00:01:15.780 and chief business officer. I'd like to remind everyone that this call includes forward-lookin...